CFH rs778294: Understanding Genetic Associations with AMD
The rs778294 variant is a non-coding genetic marker located within the CFH gene, which plays a critical role in the body's immune complement system. Research has identified this variant as part of a region strongly associated with the risk of developing age-related macular degeneration (AMD).
What each genotype means
Typical AMD risk
You carry two copies of the common A allele at this CFH locus. This genotype has not been associated with elevated risk for age-related macular degeneration in population association studies. Because complex eye conditions are influenced by many lifestyle factors and multiple genetic variants across the genome, overall risk remains dependent on broader genetic and environmental contexts.
Carried by roughly 35% to 50% of individuals of European ancestry, and is the predominant genotype in East Asian populations.
Modestly altered AMD risk marker
You carry one copy of the G alternate allele at this non-coding CFH marker. Research suggests this variant tracks alongside major risk haplotypes in the complement factor H region on chromosome 1q31.3 that are modestly associated with age-related macular degeneration. However, evidence directly implicating this specific intronic variant independently of primary causal drivers like Y402H remains limited and largely correlation-based.
Carried by approximately 40% to 50% of individuals of European ancestry, but observed at lower frequencies in Asian populations.
Elevated AMD risk marker profile
You carry two copies of the G allele at rs778294. In genome-wide and candidate-gene studies, carrying this homozygous genotype correlates with higher statistical odds of developing age-related macular degeneration due to strong linkage disequilibrium across the CFH gene cluster. This statistical correlation does not represent a diagnosis or certainty of eye disease, as overall macular health involves diverse genetic and environmental contributors.
Carried by approximately 10% to 16% of individuals of European ancestry, and is relatively uncommon in East Asian groups.
What is rs778294?
The rs778294 variant is a single-nucleotide polymorphism (SNP) located within the CFH gene on chromosome 1. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is categorized as non-coding, meaning it does not directly alter the sequence of amino acids that make up a protein. Instead, such variants are often studied for their potential to influence how genes are regulated or expressed. Because rs778294 sits within a region of high linkage disequilibrium, it is frequently inherited alongside other nearby genetic markers. This means that when researchers observe an association between this SNP and a health condition, it may be acting as a proxy for other functional changes in the surrounding genomic neighborhood rather than being the direct cause of the effect itself.
The Role of the CFH Gene
The CFH gene provides instructions for making a protein called complement factor H. This protein is a vital component of the complement system, which is a part of the innate immune system that helps the body identify and clear away damaged cells, debris, and pathogens. Complement factor H specifically acts as a regulator, preventing the complement system from becoming overactive and damaging the body's own healthy tissues. In the eye, the complement system is active in the retina, where it helps maintain the health of the retinal pigment epithelium. When the regulation of this system is disrupted, it can lead to chronic inflammation and the accumulation of deposits known as drusen, which are a hallmark of age-related macular degeneration (AMD). Genetic variations in this gene are therefore of significant interest to researchers studying how immune regulation impacts long-term eye health.
Research and Evidence Strength
The association between the CFH locus and AMD is one of the most well-replicated findings in modern human genetics. Since the initial discovery of the link in 2005, numerous genome-wide association studies (GWAS) have confirmed that variants in this region significantly influence the risk of developing AMD. While the evidence for the CFH locus as a whole is robust, the specific evidence strength for rs778294 is considered limited in isolation. This is because the region contains many variants that are tightly linked, making it difficult for scientists to pinpoint which specific SNP is the primary driver of the observed risk. Current research suggests that the risk is likely polygenic, involving multiple variants across the CFH and CFHR gene cluster. Consequently, while rs778294 is a useful marker for identifying individuals who may have a higher genetic predisposition, it is part of a complex landscape of risk factors rather than a single diagnostic indicator.
Population Frequency
The rs778294 variant is relatively common, particularly in populations of European ancestry. Data from large-scale genomic databases indicate that the minor allele frequency for this variant typically ranges between 0.30 and 0.40 in these groups. Because the variant is common, a significant portion of the population carries at least one copy of the allele. It is important to note that genetic frequency can vary significantly across different global populations, and the associations observed in European cohorts may not be identical in other ancestral groups. Researchers continue to study these differences to better understand the global architecture of AMD risk. The high frequency of this variant underscores that while it is associated with increased risk, it is a normal part of human genetic diversity and does not, by itself, determine an individual's health outcome.
What This Information Means for You
Understanding your genotype for rs778294 provides insight into your genetic predisposition, but it is not a medical diagnosis. AMD is a complex, multifactorial condition influenced by a combination of genetics, age, and environmental factors such as smoking and diet. Having a risk-associated genotype does not mean you will develop the condition, nor does having a neutral genotype guarantee protection. This information should be viewed as one piece of a much larger puzzle. If you are concerned about your eye health or have a family history of macular degeneration, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can provide comprehensive screenings and personalized advice on lifestyle choices that support long-term retinal health. Always discuss any genetic findings with a qualified clinician who can interpret them within the context of your overall health history.
How common is this variant?
The minor allele frequency for rs778294 is approximately 0.30 to 0.40 in European ancestries, making it a common variant in these populations.
Frequently asked questions
Does having the risk genotype mean I will get AMD?
No. Genetic risk factors indicate a statistical predisposition, not a certainty. Many people with risk-associated genotypes never develop the condition, as environmental and lifestyle factors play a major role.
Can I change my risk by changing my diet?
While specific dietary patterns are often studied in relation to eye health, you should consult with your doctor or a registered dietitian before making significant changes. They can provide evidence-based guidance tailored to your specific health needs.
Is there a test to see if I have this variant?
Yes, this variant is included in many commercial genetic testing panels. However, these tests are for informational purposes and should not be used to self-diagnose or replace professional medical advice.
What should I do if I know I have the risk allele?
The best course of action is to schedule regular comprehensive eye exams with an eye care professional. They can monitor your retinal health and provide personalized recommendations based on your clinical status.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs778294?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This regulatory variant in the CFH locus is linked to complement system dysregulation and is a recognized genetic risk factor for age-related macular degeneration.
This variant in the complement factor H gene is associated with altered regulation of the alternative complement pathway and increased susceptibility to age-related macular degeneration.
Intronic single nucleotide variant in the CFH region associated with susceptibility to age-related macular degeneration (AMD).
Common variant in the CFH locus strongly associated with risk of age-related macular degeneration (AMD).
Intronic marker in CFH forming critical susceptibility haplotypes for choroidal neovascularization and macular atrophy.
Intergenic/intronic variant within the CFH cluster contributing to phenotypic variation in retinal complement activation.